![]() PHAXIAM Therapeutics PHAXIAM Therapeutics (formerly known as Erytech Pharma) is a biopharmaceutical company that develops enzyme-based medicinal products for the oncology, hematology, and immunology sectors. | ![]() Genentech Genentech is a biotechnology company that discovers, develops, manufactures, and commercializes medicines. | Livzon Pharmaceutical Group Livzon Pharmaceutical Group (丽珠医药集团股份有限公司, 丽珠医药) is a pharmaceutical company that engages in the development and production of active pharmaceutical ingredients, biological drugs, diagnostic reagents, and other products. | |
Founding Date | Founding Date 2004 | Founding Date 1976 | Founding Date 1985 |
Type | Type Public | Type Subsidiary | Type Public |
Tags | |||
Locations | Locations Lyon, FR HQ Cambridge, US Princeton, US | Locations South San Francisco, US HQ Hillsboro, US Oceanside, US Portland, US South San Francisco, US South San Francisco, US South San Francisco, US see more | Locations Zhuhai, CN HQ Chengdu, CN Qingyuan, CN Shanghai, CN Shaoguan, CN Shenzhen, CN Zhuhai, CN |
Employees | Employees 49 | Employees 18,077 | Employees 9,067 |
Valuation ($) | Valuation ($) 52.8 m | Valuation ($) N/A | Valuation ($) 4.2 b |
Financial | |||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) N/A | Revenue (est.) ¥11.7b (FY, 2025) |
Cost of goods | Cost of goods N/A | Cost of goods N/A | Cost of goods ¥4.1b (FY, 2025) |
Gross profit | Gross profit €1.3m (FY, 2023) | Gross profit N/A | Gross profit ¥7.8b (FY, 2025) |
Net income | Net income (€23.5m) (FY, 2023) | Net income N/A | Net income ¥2.4b (FY, 2025) |

Genentech is a biotechnology company that discovers, develops, manufactures, and commercializes medicines.
View companyLivzon Pharmaceutical Group (丽珠医药集团股份有限公司, 丽珠医药) is a pharmaceutical company that engages in the development and production of active pharmaceutical ingredients, biological drugs, diagnostic reagents, and other products.
View company